OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
30057656

Shenzhen Rongda Photosensitive & Technology Co Ltd

Specialty ChemicalsVerified

The company maintains a strong liquidity position, with a current ratio of 3.53, indicating that it has more than three times as many current assets as current liabilities. However, its free cash flow is relatively low at 5.7 million CNY, and capital expenditures are negative at -120.7 million CNY, suggesting that the company is generating more cash than it is spending on capital investments. The company has a very low debt-to-equity ratio of 0, indicating that it is not using significant leverage in its capital structure. In terms of profitability, the company has a return on equity (ROE) of 6.9% and a return on assets (ROA) of 5.65%. These figures are below the typical thresholds for high-performing specialty chemical firms, suggesting that the company is not generating returns at the upper end of the industry spectrum. The gross profit margin is 36.8%, and the operating margin is 13.6%, which are in line with the industry but not exceptional. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. Geographically, the company is based in China, and there is no indication of significant international operations. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory is not clearly defined in the available data, as no forward-looking revenue guidance is provided. However, the negative capital expenditures suggest that the company is not currently investing heavily in expansion or new projects. The company's net income has grown from 118.1 million CNY in the most recent period, but without prior-year data, it is difficult to assess the trend. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of concern is that the company has negative net cash after subtracting total debt, which could indicate potential liquidity constraints in the short term. The dilution risk is low, as the number of shares outstanding is the same for both basic and diluted shares, indicating no potential for share dilution from stock options or convertible securities. There are no recent events or filings mentioned in the available data that would significantly impact the company's operations or financial position. The company's financial statements do not indicate any material legal or regulatory issues, and there are no recent earnings call transcripts or press releases that would provide additional insight into the company's strategic direction.

30-day price · 300576+11.95 (+36.3%)
Low$32.93High$47.30Close$44.88As of21 May, 00:00 UTC
Profile
CompanyShenzhen Rongda Photosensitive & Technology Co Ltd
Ticker300576.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Shenzhen Rongda Photosensitive & Technology Co Ltd is a specialty chemicals company that produces and sells photosensitive materials and related chemical products, primarily serving the electronics and photovoltaic industries.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry, with a classification confidence of 0.92.

The company maintains a strong liquidity position, with a current ratio of 3.53, indicating that it has more than three times as many current assets as current liabilities. However, its free cash flow is relatively low at 5.7 million CNY, and capital expenditures are negative at -120.7 million CNY, suggesting that the company is generating more cash than it is spending on capital investments. The company has a very low debt-to-equity ratio of 0, indicating that it is not using significant leverage in its capital structure. In terms of profitability, the company has a return on equity (ROE) of 6.9% and a return on assets (ROA) of 5.65%. These figures are below the typical thresholds for high-performing specialty chemical firms, suggesting that the company is not generating returns at the upper end of the industry spectrum. The gross profit margin is 36.8%, and the operating margin is 13.6%, which are in line with the industry but not exceptional. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. Geographically, the company is based in China, and there is no indication of significant international operations. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory is not clearly defined in the available data, as no forward-looking revenue guidance is provided. However, the negative capital expenditures suggest that the company is not currently investing heavily in expansion or new projects. The company's net income has grown from 118.1 million CNY in the most recent period, but without prior-year data, it is difficult to assess the trend. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of concern is that the company has negative net cash after subtracting total debt, which could indicate potential liquidity constraints in the short term. The dilution risk is low, as the number of shares outstanding is the same for both basic and diluted shares, indicating no potential for share dilution from stock options or convertible securities. There are no recent events or filings mentioned in the available data that would significantly impact the company's operations or financial position. The company's financial statements do not indicate any material legal or regulatory issues, and there are no recent earnings call transcripts or press releases that would provide additional insight into the company's strategic direction.
Key takeaways
  • The company has a strong current ratio of 3.53, indicating a solid short-term liquidity position.
  • The company's ROE of 6.9% and ROA of 5.65% are in line with industry norms but not exceptional.
  • The company is not using significant leverage, as evidenced by its debt-to-equity ratio of 0.
  • The company's free cash flow is relatively low, and capital expenditures are negative, suggesting limited investment in growth.
  • The company's revenue is concentrated in a single business segment and geographic region, which may increase its exposure to regional risks.
  • The company has a low dilution risk, as there is no difference between basic and diluted shares outstanding.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$1.07B
Gross profit$393.2M
Operating income$145.6M
Net income$118.1M
R&D
SG&A
D&A
SBC
Operating cash flow$105.0M
CapEx-$120.7M
Free cash flow$5.7M
Total assets$2.09B
Total liabilities$380.4M
Total equity$1.71B
Cash & equivalents
Long-term debt$7.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.71B
Net cash-$7.0M
Current ratio3.5
Debt/Equity0.0
ROA5.7%
ROE6.9%
Cash conversion89.0%
CapEx/Revenue-11.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric300576Activity
Op margin13.6%0.4% medp25 -8.0% · p75 16.0%above median
Net margin11.1%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin36.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-11.3%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity0.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 03:47 UTCJob: 3a7656f6